1-5 of 5
Reyes Arranz, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Dose Therapy with Autologous Stem Cell Transplantation (HDT/ASCT) Support in Follicular Lymphoma (FL) a Very Long Follow-up Analysis of 640 Patients of Geltamo Spanish Group Suggests That FL Might be Cured, Even in High-Risk Patients

Ana Jiménez Ubieto, Carlos Grande García, MD, Lucrecia Yáñez, MD, Dolores Caballero, Silvana Novelli, MD, María Jesús Rodriguez, María Manzanares, Reyes Arranz, MD PhD, Jose Javier Ferreiro, MD, Sabella Bobillo, Santiago Mercadel, Andrea Galeo, Javier López, Carlos Vallejo, Carmen Albo, Elena Perez, Carmen Marrero, MD, Laura Magnano, MD, Luis Palomera, Isidro Jarque, Erika Coria, Teresa Palomo, Juan José Lahuerta, MD PhD, Armando Lopez-Guillermo, Antonio Salar, MD
Journal: Blood
Blood (2014) 124 (21): 675.
https://doi.org/10.1182/blood.V124.21.675.675
Published: 2014
Journal Articles

Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011)

Ana García-Noblejas, MD, Eulogio Conde, MD PhD, Alejandro Martín, MD, María Jesús Vidal, MD, Rafael Rojas, PhD, Carlos Grande, MD, María José Ramirez, MD, Jimena Cannata-Ortiz, MD, Juan Carlos García-Ruiz, MD, Javier Briones, MD, Andrés Lopez, MD, Pablo Ríos Rull, MD, Victor Noriega, MD, Guillermo Deben, MD, Eva González Barca, MD PhD, Sonia González de Villambrosia, MD, Jose Javier Ferreiro, MD, Juan José Lahuerta, MD PhD, Maria Dolores Caballero, MD PhD, Reyes Arranz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3980.
https://doi.org/10.1182/blood.V124.21.3980.3980
Published: 2014
Journal Articles

Outcome and Long Term Toxicity of the LNH- PRO Trial after 12 Year Median Follow-up, in Patients with Indolent Non Hodgkin's Lymphoma Who Received Immunochemotherapy with CVP and Interferon-alfa2b (IFNα2b)

Jimena Cannata-Ortiz, MD, Concepción Nicolás, MD, Ana García-Noblejas, MD, Javier Lopez, Pilar Sabin, Pilar Zamora, Maria José Requena, Reyes Arranz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4465.
https://doi.org/10.1182/blood.V124.21.4465.4465
Published: 2014
Journal Articles

A Phase 2 Study from Spanish Geltamo Group Investigating the Efficacy and Safety of Bendamustine As Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients with Aggressive Lymphomas: Second Interim Analysis

Alejandro Martín, Alba María Redondo, David Valcárcel, Ana Pilar Gonzalez, Armando López-Guillermo, José Luis Bello, Miguel A. Canales, MD PhD, Jorge Gayoso, MD, Eulogio Conde, MD PhD, Isidro Jarque, Raquel Del campo, Reyes Arranz, MD PhD, María-José Terol, MD PhD, Jose J. Rifon, MD, María-José Rodríguez, María-José Ramírez, Carlos Grande, Andrés Sánchez, Javier López-Jiménez, Dolores Caballero
Journal: Blood
Blood (2014) 124 (21): 2524.
https://doi.org/10.1182/blood.V124.21.2524.2524
Published: 2014
Journal Articles

Peripheral T/NK-Cell Lymphomas: Survival with Current Treatment Strategies. La Princesa University Hospital Single Experience

Miriam González-Pardo, Carlos Fernández-Arandojo, Jimena Cannata, Beatriz Aguado, Ana García-Noblejas, MD, Adrian Alegre, Reyes Arranz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5897.
https://doi.org/10.1182/blood.V124.21.5897.5897
Published: 2014